| Literature DB >> 21777817 |
Filippos Kottakis1, Christos Polytarchou, Parthena Foltopoulou, Ioannis Sanidas, Sotirios C Kampranis, Philip N Tsichlis.
Abstract
The histone H3K27 methyltransferase EZH2 plays an important role in oncogenesis, by mechanisms that are incompletely understood. Here, we show that the JmjC domain histone H3 demethylase NDY1 synergizes with EZH2 to silence the EZH2 inhibitor miR-101. NDY1 and EZH2 repress miR-101 by binding its promoter in concert, via a process triggered by upregulation of NDY1. Whereas EZH2 binding depends on NDY1, the latter binds independently of EZH2. However, both are required to repress transcription. NDY1 and EZH2 acting in concert upregulate EZH2 and stabilize the repression of miR-101 and its outcome. NDY1 is induced by FGF-2 via CREB phosphorylation and activation, downstream of DYRK1A, and mediates the FGF-2 and EZH2 effects on cell proliferation, migration, and angiogenesis. The FGF-2-NDY1/EZH2-miR-101-EZH2 axis described here was found to be active in bladder cancer. These data delineate an oncogenic pathway that functionally links FGF-2 with EZH2 via NDY1 and miR-101.Entities:
Mesh：
Substances：
Year: 2011 PMID： 21777817 PMCID： PMC3324394 DOI： 10.1016/j.molcel.2011.06.020
Source DB: PubMed Journal: Mol Cell ISSN： 1097-2765 Impact factor: 17.970